Literature DB >> 11682546

Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection.

K H Chan1, M H Ng, W H Seto, J S Peiris.   

Abstract

Detection of Epstein-Barr Virus (EBV) DNA by PCR in serum had a sensitivity of 80%, a specificity of 94%, and positive and negative predictive values of 95 and 79%, respectively, for the diagnosis of primary EBV infection. We suggest that this is a useful addition to the panel of tests used for this purpose.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11682546      PMCID： PMC88503          DOI： 10.1128/JCM.39.11.4152-4154;2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Development and evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay based on the 18-kilodalton matrix protein for diagnosis of primary EBV infection.

Authors:  K H Chan; R X Luo; H L Chen; M H Ng; W H Seto; J S Peiris
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

2.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation.

Authors:  J J Gray
Journal:  J Virol Methods       Date:  1995-03       Impact factor: 2.014

4.  Epstein-Barr virus (EBV) infection in infancy.

Authors:  K H Chan; J S Tam; J S Peiris; W H Seto; M H Ng
Journal:  J Clin Virol       Date:  2001-04       Impact factor: 3.168

5.  Quantitation of Epstein-Barr virus DNA in the blood of adult liver transplant recipients.

Authors:  D Mutimer; N Kaur; H Tang; S Singhal; J Shaw; L Whitehead; A Rickinson; G Niedobitek
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

6.  Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.

Authors:  W Hinderer; D Lang; M Rothe; R Vornhagen; H H Sonneborn; H Wolf
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Detection of cell-free Epstein-Barr virus DNA in serum during acute infectious mononucleosis.

Authors:  Y J Gan; J L Sullivan; J W Sixbey
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

8.  Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.

Authors:  S A Riddler; M C Breinig; J L McKnight
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

9.  Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis.

Authors:  F de Ory; J Antonaya; M V Fernández; J M Echevarría
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

10.  Early diagnosis of primary human herpesvirus 6 infection in childhood: serology, polymerase chain reaction, and virus load.

Authors:  S S Chiu; C Y Cheung; C Y Tse; M Peiris
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226
View more
  21 in total

1.  Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing.

Authors:  Yasuo Sugita; Mizuhiko Terasaki; Daisuke Niino; Koichi Ohshima; Arakawa Fumiko; Minoru Shigemori; Yasuharu Sato; Naoko Asano
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 2.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

Review 4.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

5.  Severe thrombocytopenia and recurrent epistaxis associated with primary Epstein-Barr virus infection.

Authors:  William Tilden; Shahnawaz Valliani
Journal:  BMJ Case Rep       Date:  2015-04-09

6.  Long-term follow-up of Epstein-Barr virus viremia in pediatric recipients of renal transplants.

Authors:  Tahar Hadou; Jean Luc André; Rosine Bourquard; Marie Jeanne Krier-Coudert; Véronique Venard; Alain Le Faou
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

7.  Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern.

Authors:  Massimo De Paschale; Debora Cagnin; Teresa Cerulli; Maria Teresa Manco; Carlo Agrappi; Paola Mirri; Arianna Gatti; Cristina Rescaldani; Pierangelo Clerici
Journal:  Int J Microbiol       Date:  2010-06-20

8.  Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients.

Authors:  Dayana Bravo; Beatriz Muñoz-Cobo; Elisa Costa; M Angeles Clari; Nuria Tormo; David Navarro
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

9.  Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection.

Authors:  K H Chan; K Sonnenberg; M Niedrig; S Y Lam; C M Pang; K M Chan; S K Ma; W H Seto; J S M Peiris
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

10.  Return to play after infectious mononucleosis.

Authors:  Jonathan A Becker; Julie Anne Smith
Journal:  Sports Health       Date:  2014-05       Impact factor: 3.843
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.